CONTROVERSIES AND EVIDENCE: PELVIC LYMPH NODE MANAGEMENT IN HIGH-RISK PROSTATE CANCER

Controversies and Evidence: Pelvic Lymph Node Management in High-Risk Prostate Cancer

Controversies and Evidence: Pelvic Lymph Node Management in High-Risk Prostate Cancer

September 11, 2024
7am PDT | 10am EDT | 4pm CEST | 7.30pm IST | 10pm HKT

The webinar's learning objectives include: 

Understanding pelvic lymph node management: Delve into the importance of managing pelvic lymph nodes in treating high-risk prostate cancer. 

Examining evidence and controversies: Review the current research on the prevalence, risk factors and management of pelvic toxicity after radiotherapy to the lymph nodes in prostate cancer.